Skip to content

Semantic Analysis by spaCy

Hoechst Pharmaceuticals Vs. C.V.S. Mani

Decided On : Aug-13-1982

Court : Delhi

Notice (8): Undefined index: topics [APP/View/Case/meta.ctp, line 36]
Warning (2): Invalid argument supplied for foreach() [APP/View/Case/meta.ctp, line 39]

LAW: Constitution, Section 49, Section 1 of the Act, Section 2, the Dangerous Drugs Act, Section 3 of the Act, Section 6, Chapter Ii, Chapter Ii, Section 8, Chapter, Section 9A(e, Chapter III, Section 12(1, Section 13, Chapter Iii, Section 11, Section 14, Section 13, Chapter Iv, Section 16, Section 17, Chapter IV, Section 9(e, Chapter III, Section 18, Section 27, Chapter, Section 33, Chapter IV, Section 2(q, Section 25, Section 28 and Section 46, Section 2(q, Section 25, Section 28, Section 46, Section 2(q).These, Rule 96, Section 12, Section 33, Chapter Iv, Section 33(1, Constitution, the Chairmanship ofShri Jaisukhial Hathi, Chapter X, Constitution, Section 2, Section 12 and Section 33, Section 2, Section 12, Chapter III, Section 33, Chapter Iv, Section 12, Section 33, Rule 96, Section 2, the TradeMarks Act, Article 14 and 19 of the Constitution, Section 12, Chapter III, Section 2, Section 12, Rule 96, theTrade Marks Act, Section 2 of the Act, Chapter X of the Committee Report, the Essential Commodities Act, Article 14 of the Constitution, Article 19(l)(g, Constitution, Article 19 of the Constitution, Rule 96, Constitution, Rule 96

PERSON: Prakash Narain, Drugs, Gazette, Pfizer Limited, C. V. S. Mani, Pfizer, Verban, Cosme Farma, Articles 13, Novalgin, Novalgin, Betapressin, Novalgin, Novalgia'.(7, Chapter Iii, theBoard, Manner, N.F.I., inSchedule W, Schedule V, TD/83-64, X-1101317199-D&MS;)C. V. S. Mani, Analgin, Aspirin, Novalgin, Prescriber, Acetyl Salicylic acid)(iii, Analgin, Ferrous Sulphate, Rules 30A, interalia, theTable, Draft, Articles 14, Novalgin, Novalgin, Idpl, Novalgin, Betapressin, Acthas, Sheth v. State, Chapter Iii, Gazette, Jagjivandas Sheth, Cyanamid andPfizer, Aspirin, K Dalmia v. Tendulkar, Cosme Farma, Articles 14

CARDINAL: 1, 6, 33, four, 30A, 69B, 1, 2, 19, four, 1605, 1981.(4, 1, 2, 3, 20 to 24, theseRules, 96, 1, 124, 1, 1981.(2, 2(b, 2(0, 3, 96, 1, 30A, 69B, 96(l)(i)(B, 1, 25, 28, Act.(12, two, two, two, two, thatin, 13, 13drugs, 13, five, two, 1980and, 5, 12, 96, 1, 12, 33, 14, 13, 13, 1,2, 3, 1975.The, 13, 17/01/1981.The, 19, 4, 1605, 1, 2, 3, five, two, 12, one, 24, 12, 33, three, one, five, 12, 2, 33, 1, 13, 3, 13, five, 13, five, 1959]1SCR279, only five, 13, five, one, one, two, 4, three, five, 550

DATE: 1940, 12, 1945, 17/01/1981, 1/08/1981, 17/01/1981, 1981, 1719of 1981, 14, 1956, 148999, 225514, 1958, 1958, 1930, '96, '1, onthe 1st day of August, 1981, 1945, April, 1975, 1966, 29/03/1978, 1978, February 8, 8/08/1980, 8/02/1980, May 9, 1980, 19/05/1980, 18/09/1972, 21/10/1980, January 17, 1981, 69B, 8/02/1974, April, March, 1978, 29/03/1978, 16/08/1980, 1981, 1966]2SCR110, 1940, 33, 17/01/1981, 19(l)(g, 2(b

ORG: theDrags and Cosmetics Rules, The Central Government, the Central Government, Hoechst Pharmaceuticals Ltd., Cyanamid India Limited, Cosme Farma Laboratories, the Government of India, theMinistry of Health and Family Welfare, issued),the Union of India, the Organisation of Pharmaceutical Producers, Hoechst, Vermex, inter alia, the Trade Marks Act, Analgin, Analgin, Analgin, Metamizols, Hoechst, Betapressin, to'Betapressin, the Actand the Rules, toas the Trade Marks Act.(8, byan authority, the Central Government, the Drugs Technical Advisory Board, the CentralDrugs Laboratory, the Drugs Consultative Committeecontemplated, Sections 5, empowersthe Central Government, the DrugsTechnical Advisory Board, the Official Gazette, manufactureana, inter alia, Chapter Iv, Chapter IX, I.P., the National Formularyof India, the WorldHealth Organisation, Drugs andCosmetics, Schedule W, Schedule, salts.(No, the Trade Marks Act, inter alia, Analgin, inter alia, the Committee on Drugs and Pharmaceutical Industry, the Hathi Committee, Parliament, inter alia, TheCommittee, TheCommittee, Committee, the Indian National Formulary, The Hathi Committee, the Central Government, the Table of the Lok Sabha, Drug Policy, TheNew Drug Policy, Hathi Committee, Hathi Committee, the Central Government, Adipate, Citrate, the Indian Drug Manufacturers' Association of India, the Central Government, Contrary, beforethe Hathi Committee, the Central Government, The Central Government, the Drugs Advisory Board, inter alia, the Central Government, inter alia, theCentral Government, The Hathi Committee, profit;(e, Hathi Committee, Drug Control Inspection Organisation, Hathi Committee, and(m, the Drug Organisation, the Ministry ofPetroleum & Chemicals, Drugsand Pharmaceuticals, Committeesubmitted, Hathi Committee, Committee, Committee, TheHathi Committee, Committee, Indianisation, The 'Committee, Indian Medical Association, Organisation ofthe Pharmaceutical Producers of, Indian Drugs Manufacturers Association of India, the Development Council for Drugs andPharmaceuticals, Committee, Committee, Committee, CentralGovernment, Government, the Government of India, Shri Panchapakesan, the Indian Drug Industry, the Union of India, TheHathi Committee, the Government of India, Analgin-Hoechst', this Hon'ble Court, the Govenment of India, Consumer Education, Indian Drugs and Pharmaceutical Private Ltd., relevance.(19, Legislature, Indian Chemical, PharmaceuticalWorks, Hyderabad, The State of Andhra Pradesh, Supreme Courtit, the Central Government, the Central Government, Board, theIndian Chemical and Pharmaceutical Works, the Supreme Court, Central Government, the Hathi Committee, Hoechst, Hathi Committee's, Mejarol, an Indian Company, Cosme Farme, un, the Trade Marks Act, the Trade Marks Act, the Trade Marks Act, Hoechst, The Hathi Committee, the Hathi Committee, the Central Government, the Hathi Committee, the Central Government, Schedule 'W', Hathi Committee, the Central Government, the Supreme Court, the Central Government, The Hathi Committee, the Hathi Committee, the Drugs(Prices Control) Order, Schedule 'W, the Hathi Committee, Schedule 'W', the Trade Marks Act, Hoechst, Mejoral, Mejoralmeant, BabyAspirin, experience.(30, Schedule 'W

GPE: New Delhi, India, India, Hoechstmatter, Federal Republic of Germany, India, Dipyrone'.(5, ChapterIII, India, suchlabels;'(9, Labelling, the United Kingdom, United States, Aspirin, Schedule'W, India, India, C.W., Research Centre, Ahmedabad, India, India, India, Explanationn, India

NORP: whichthese, and3, Rules, Indian, Rules, Chlorpremazine, Indian, Indian, theIndian, Novalgin, Novalgin, Indian

ORDINAL: second, first, first, Second, first, first, first, second, first, 4th, 4th, 4th, first, first, first

MONEY: 50 per cent, TheTrade Marks Act

EVENT: the Second Schedule

PRODUCT: Schedule F, theSchedule

LOC: with13, Chapter Iii, aforesaid5

FAC: the Gazette ofIndia, the Lok Sabha

TIME: 33 of the Act, 33 of the Act, 33 of the Act

WORK_OF_ART: The Preamble of the Act, 'The Drugs Act

View Full Judgment


Save Judgments// Add Notes // Store Search Result sets // Organize Client Files //